Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.

Corley SD, Epstein AE, DiMarco JP, Domanski MJ, Geller N, Greene HL, Josephson RA, Kellen JC, Klein RC, Krahn AD, Mickel M, Mitchell LB, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG; AFFIRM Investigators.

Circulation. 2004 Mar 30;109(12):1509-13. Epub 2004 Mar 8.

2.

A comparison of rate control and rhythm control in patients with atrial fibrillation.

Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators.

N Engl J Med. 2002 Dec 5;347(23):1825-33.

3.

Occurrence and characteristics of stroke events in the Atrial Fibrillation Follow-up Investigation of Sinus Rhythm Management (AFFIRM) study.

Sherman DG, Kim SG, Boop BS, Corley SD, Dimarco JP, Hart RG, Haywood LJ, Hoyte K, Kaufman ES, Kim MH, Nasco E, Waldo AL; National Heart, Lung, and Blood Institute AFFIRM Investigators.

Arch Intern Med. 2005 May 23;165(10):1185-91.

PMID:
15911734
4.

Is rhythm-control superior to rate-control in patients with atrial fibrillation and diastolic heart failure?

Kong MH, Shaw LK, O'Connor C, Califf RM, Blazing MA, Al-Khatib SM.

Ann Noninvasive Electrocardiol. 2010 Jul;15(3):209-17. doi: 10.1111/j.1542-474X.2010.00365.x.

PMID:
20645962
5.

Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

DiMarco JP, Flaker G, Waldo AL, Corley SD, Greene HL, Safford RE, Rosenfeld LE, Mitrani G, Nemeth M; AFFIRM Investigators.

Am Heart J. 2005 Apr;149(4):650-6.

PMID:
15990748
6.

Atrial fibrillation: rate control often better than rhythm control.

[No authors listed]

Prescrire Int. 2004 Apr;13(70):64-9.

PMID:
15148984
7.

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.

Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.

Am J Cardiol. 2003 Mar 20;91(6A):15D-26D. Review.

PMID:
12670638
8.

A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ; Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group.

N Engl J Med. 2002 Dec 5;347(23):1834-40.

9.

Rate-control versus conversion strategy in postoperative atrial fibrillation: trial design and pilot study results.

Lee JK, Klein GJ, Krahn AD, Yee R, Zarnke K, Simpson C, Skanes A.

Card Electrophysiol Rev. 2003 Jun;7(2):178-84.

PMID:
14618047
10.

Pharmacologic management of atrial fibrillation: current therapeutic strategies.

Lévy S.

Am Heart J. 2001 Feb;141(2 Suppl):S15-21. Review.

PMID:
11174354
11.

A randomised, controlled study of rate versus rhythm control in patients with chronic atrial fibrillation and heart failure: (CAFE-II Study).

Shelton RJ, Clark AL, Goode K, Rigby AS, Houghton T, Kaye GC, Cleland JG.

Heart. 2009 Jun;95(11):924-30. doi: 10.1136/hrt.2008.158931. Epub 2009 Mar 11.

PMID:
19282313
12.

Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

Curtis AB, Gersh BJ, Corley SD, DiMarco JP, Domanski MJ, Geller N, Greene HL, Kellen JC, Mickel M, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG; AFFIRM Investigators.

Am Heart J. 2005 Apr;149(4):645-9.

PMID:
15990747
13.

Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure?

Al-Khatib SM, Shaw LK, Lee KL, O'Connor C, Califf RM.

Am J Cardiol. 2004 Sep 15;94(6):797-800.

PMID:
15374794
14.

Rate-control treatment and mortality in atrial fibrillation.

Chao TF, Liu CJ, Tuan TC, Chen SJ, Wang KL, Lin YJ, Chang SL, Lo LW, Hu YF, Chen TJ, Chiang CE, Chen SA.

Circulation. 2015 Oct 27;132(17):1604-12. doi: 10.1161/CIRCULATIONAHA.114.013709. Epub 2015 Sep 17.

15.

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.

Gillis AM, Verma A, Talajic M, Nattel S, Dorian P; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2011 Jan-Feb;27(1):47-59. doi: 10.1016/j.cjca.2010.11.001. Erratum in: Can J Cardiol. 2011 May-Jun;27(3):388.

PMID:
21329862
16.

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.

Lafuente-Lafuente C, Valembois L, Bergmann JF, Belmin J.

Cochrane Database Syst Rev. 2015 Mar 28;(3):CD005049. doi: 10.1002/14651858.CD005049.pub4. Review.

PMID:
25820938
17.

The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.

Olshansky B, Rosenfeld LE, Warner AL, Solomon AJ, O'Neill G, Sharma A, Platia E, Feld GK, Akiyama T, Brodsky MA, Greene HL; AFFIRM Investigators.

J Am Coll Cardiol. 2004 Apr 7;43(7):1201-8.

18.

AFFIRM and RACE trials: implications for the management of atrial fibrillation.

Blackshear JL, Safford RE; AFFIRM trial; RACE trial.

Card Electrophysiol Rev. 2003 Dec;7(4):366-9. Review.

PMID:
15071255
19.

Rhythm versus rate control in the contemporary management of atrial fibrillation in-hospital.

Allen Lapointe NM, Sun JL, Kaplan S, d'Almada P, Al-Khatib SM.

Am J Cardiol. 2008 Apr 15;101(8):1134-41. doi: 10.1016/j.amjcard.2007.11.067. Epub 2008 Feb 7.

PMID:
18394447
20.

Supplemental Content

Support Center